Array Biopharma (ARRY) Misses Q2 EPS by 11c
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Price: $8.54 --0%
EPS Growth %: -48.0%
Financial Fact:
Total revenue: 39.27M
Today's EPS Names:
JFIN, KEQU, LASE, More
EPS Growth %: -48.0%
Financial Fact:
Total revenue: 39.27M
Today's EPS Names:
JFIN, KEQU, LASE, More
Join SI Premium – FREE
Array Biopharma (NASDAQ: ARRY) reported Q2 EPS of ($0.17), $0.11 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $35.4 million versus the consensus estimate of $32.7 million.
For earnings history and earnings-related data on Array Biopharma (ARRY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- NVE Corporation names new CEO and expands board to seven members
- Sun Communities names Ileana McAlary as general counsel and EVP
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
